Generic drug industry blue ribbon panel
Lead-off speakers at June 20 hearing are Center for Drug Evaluation and Research Director Carl Peck, MD, and Office of Generic Drugs Acting Director Bruce Burlington, MD, followed by speakers representing the generic industry, testing labs, health insurers and medical professional societies. Established by the Generic Pharmaceutical Industry Association and chaired by former PMA President Lewis Engman, the panel convenes at 9:00 a.m. at the Georgetown University Hotel and Conference Center in Washington, D.C.
You may also be interested in...
CBER Director Peter Marks said the agency could streamline development by allowing sponsors to depend on an already-approved manufacturing platform and reviewing any modifications that are proposed.
Only 12 US jurisdictions currently have sound COVID-19 virus assays from the Centers for Disease Control and Prevention to test suspected virus cases, CDC director Robert Redfield told a House panel looking at virus preparedness on Wednesday – but a better batch is coming, he said. Other questions raised at the congressional hearing was how long an infected person stays infected, whether COVID-19 can be picked up from inanimate surfaces, and related queries.
Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.